Magnolia NeuroSciences Company
Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
Investors
%20.jpg)
Founded Date:
2018
Investor Type:
N/A
Employee Number:
1-10
Investment Stage:
N/A
Funding Status:
N/A
Number Of Exists:
N/A
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
New York, New York, United States
Estimated Revenue:
Less than $1M